SG Americas Securities, LLC - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G901. A total of 7 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q4 2017$66,000
-80.2%
71,1000.0%0.00%
-66.7%
Q3 2017$334,000
+8250.0%
71,100
+407.9%
0.00%
Q4 2016$4,000
-88.2%
14,0000.0%0.00%
Q3 2016$34,000
+61.9%
14,0000.0%0.00%
Q2 2016$21,000
-57.1%
14,0000.0%0.00%
Q1 2016$49,000
-74.9%
14,0000.0%0.00%
-100.0%
Q4 2015$195,000
-31.1%
14,0000.0%0.00%
-50.0%
Q3 2015$283,000
-42.1%
14,0000.0%0.00%
-33.3%
Q2 2015$489,000
+27.0%
14,0000.0%0.00%
+50.0%
Q1 2015$385,00014,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q1 2017
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,969$17,284,0000.93%
Hudson Bay Capital Management LP 133,600$11,727,0000.16%
GROUP ONE TRADING, L.P. 46,600$4,091,0000.05%
Timber Hill LLC 28,000$2,458,0000.02%
WADDELL & REED FINANCIAL INC 25,000$2,195,0000.01%
SIMPLEX TRADING, LLC 115$34,0000.00%
Compagnie Lombard Odier SCmA 1,800$10,0000.00%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders